IL6 and COVID-19: Given that IL-6 was also reported to be aberrantly hyperactivated in many types of cancer [41], in this section, we will discuss the interplay of COVID-19 and cancer in IL-6/Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling.